Rhizome extracts of wild Curcuma species from the Sub-Himalayan Terai region, including Curcuma amada Roxb., Curcuma aromatica Salisb., and Curcuma caesia Roxb., were tested for bioactive metabolites, antioxidants, and antidiabetic properties. GC-MS profiling indicated a wide range of terpenoids, while RP-HPLC found different phenolic compounds. Curcuma aromatica Salisb. had greater levels of quercetin (865.56 ± 0.55 mg/kg) and ferulic acid (381.74 ± 0.56 mg/kg), but Curcuma caesia Roxb. had higher levels of p-coumaric acid (938.51 ± 0.67 mg/kg), total phenolics (10.76 ± 0.51 mg GAE/g), and flavonoids (7.10 ± 0.12 mg QE/g). Curcuma amada Roxb. demonstrated strong antioxidant and antiglycation activities with DPPH (IC50 61.10 ± 0.29 µg/mL), ABTS (IC50 74.62 ± 0.64 µg/mL), and antiglycation (IC50 2.33 ± 0.01 µg/mL). Curcuma aromatica Salisb. demonstrated superior metal-chelating activity (71.28%) and α-glucosidase inhibition (IC50 17.44 µg/mL). These findings highlighted the potential therapeutic value of wild Curcuma species as natural multifunctional phytochemicals.
No takes yet. Share an insight, caveat, or question.
Pramanik et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: